Impact of crisaborole & tacrolimus 0.03% on patient-reported outcomes and caregiver burden in children with atopic dermatitis

被引：0
|
作者：
Wieser, J. [1 ]
Chen, A. [2 ]
Lee, G. [1 ]
Baughman, L. [1 ]
Pope, E. M. [1 ]
Franco, A. [1 ]
Verhave, B. [1 ]
Johnson, B.
Love, T. [1 ,2 ]
Beck, L. A. [1 ]
Wolf, J. Ryan [1 ]
机构：
[1] Univ Rochester, Dermatol, Med Ctr, Rochester, NY USA
[2] Univ Rochester, Biostat, Med Ctr, Rochester, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
388
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [21] Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns
    Kleyn, C. Elise
    Barbarot, Sebastien
    Reed, Catherine
    Losi, Serena
    von Arx, Lill-Brith
    Robert, Camille
    Anderson, Peter
    Grond, Susanne
    Costanzo, Antonio
    DERMATOLOGY AND THERAPY, 2022, 12 (08) : 1947 - 1965
  • [22] Validation of patient-reported outcome measures for atopic dermatitis
    Ingram, John
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (01) : IX - IX
  • [23] The importance of patient-reported pain interference in atopic dermatitis
    Wolf, J. Ryan
    Porterfield, C.
    Beck, L. A.
    Pentland, A. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E49 - E50
  • [24] Patient-reported disease trajectory for adults with atopic dermatitis
    Grinich, Erin E.
    Chung, Janice
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB252 - AB252
  • [25] Establishing severity strata for 5 different patient-reported outcomes in adults with atopic dermatitis
    Sacotte, R.
    Vakharia, P.
    Chopra, R.
    Patel, N.
    Immaneni, S.
    White, T.
    Kantor, R.
    Hsu, D.
    Simpson, E.
    Silverberg, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S66 - S66
  • [26] Treatment of moderate and severe atopic dermatitis in children with twice weekly tacrolimus 0.03% ointment
    Reitamo, Sakari
    Allsopp, Richard
    Naidoo, Shevani
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB10 - AB10
  • [27] Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
    Jonathan I. Silverberg
    Jacob P. Thyssen
    Eric L. Simpson
    Gil Yosipovitch
    Sonja Ständer
    Hernan Valdez
    Ricardo Rojo
    Pinaki Biswas
    Daniela E. Myers
    Claire Feeney
    Marco DiBonaventura
    American Journal of Clinical Dermatology, 2021, 22 : 541 - 554
  • [28] Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Simpson, Eric L.
    Yosipovitch, Gil
    Staender, Sonja
    Valdez, Hernan
    Rojo, Ricardo
    Biswas, Pinaki
    Myers, Daniela E.
    Feeney, Claire
    DiBonaventura, Marco
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 541 - 554
  • [29] Validating the burden of disease in atopic eczema (BODE) tool as an instrument for measuring patient-reported quality of life in atopic dermatitis
    Wang, A.
    Ding, J.
    Qureshi, A. A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
  • [30] Validation of patient-reported global severity of atopic dermatitis in adults
    Vakharia, P. P.
    Chopra, R.
    Sacotte, R.
    Patel, N.
    Immaneni, S.
    White, T.
    Kantor, R.
    Hsu, D. Y.
    Silverberg, J. I.
    ALLERGY, 2018, 73 (02) : 451 - 458
12345